Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Xiamen Amoytop Biotech CoSHSE:688278 +2.94%75 PB Ratio is 6.82 as of Jul. 27, 2026, which is 42% below its 10-year median of 11.72. GuruFocus rates SHSE:688278 with a GF Score™ of 75/100 and a GF Value™ of ¥106.91 (Possible Value Trap). The stock has 1 warning sign investors should review. Among 1,230 Biotechnology companies, Xiamen Amoytop Biotech Co ranks worse than 78.05% on this metric.
The historical rank and industry rank for Xiamen Amoytop Biotech Co's PB Ratio or its related term are showing as below:
SHSE:688278'
s PB Ratio Range Over the Past 10 Years
Min: 5.95 Med: 11.72 Max: 32.75
Current: 6.82
During the past 10 years, Xiamen Amoytop Biotech Co's highest PB Ratio was 32.75. The lowest was 5.95. And the median was 11.72.
SHSE:688278's PB Ratio is ranked worse than 78.05% of 1230
companies
in the Biotechnology industry
Industry Median: 2.785
vs SHSE:688278: 6.82
During the past 12 months, Xiamen Amoytop Biotech Co's average Book Value Per Share Growth Rate was 31.60% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 34.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 28.70% per year.
During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Xiamen Amoytop Biotech Co was 34.70% per year. The lowest was 5.60% per year. And the median was 27.20% per year.
Back to Basics: PB Ratio
Xiamen Amoytop Biotech Co (SHSE:688278) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Xiamen Amoytop Biotech Co PB Ratio Related Terms
Xiamen Amoytop Biotech Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688278 vs VRTX, REGN, RVMD: PB Ratio Comparison
For the Biotechnology subindustry, Xiamen Amoytop Biotech Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xiamen Amoytop Biotech Co PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Xiamen Amoytop Biotech Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Xiamen Amoytop Biotech Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Xiamen Amoytop Biotech Co (SHSE:688278) has a PB Ratio of 6.82 as of Jul. 27, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Xiamen Amoytop Biotech Co and its competitors. This is 42% below median its historical median of 11.72. Over the past decade, Xiamen Amoytop Biotech Co's PB Ratio has ranged from 5.95 to 32.75. According to the industry distribution chart, Xiamen Amoytop Biotech Co ranks #960 out of 1230 companies in the Biotechnology industry, placing it in the top 78%.
Is Xiamen Amoytop Biotech Co's PB Ratio too high?
Xiamen Amoytop Biotech Co's current PB Ratio of 6.82 is 42% below median its 10-year median of 11.72. Over the past 10 years, this metric has ranged from a low of 5.95 to a high of 32.75. The Biotechnology industry median PB Ratio is 2.79. Xiamen Amoytop Biotech Co's value of 6.82 is 144.9% above this industry median. Based on the distribution chart, Xiamen Amoytop Biotech Co ranks #960 out of 1230 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Xiamen Amoytop Biotech Co has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Xiamen Amoytop Biotech Co's PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Xiamen Amoytop Biotech Co ranks #960 out of 1230 companies for PB Ratio. This places Xiamen Amoytop Biotech Co in the lower half of its industry. The industry median PB Ratio is 2.79. Xiamen Amoytop Biotech Co's value of 6.82 is 144.9% above this benchmark. Historically, Xiamen Amoytop Biotech Co's own PB Ratio has ranged from 5.95 to 32.75 over the past decade. While the company's 10-year median is 11.72 vs. the industry median of 2.79, Xiamen Amoytop Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.79, based on 1,230 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Xiamen Amoytop Biotech Co's current PB Ratio of 6.82 is 144.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Xiamen Amoytop Biotech Co and its competitors. For the Biotechnology industry, the median PB Ratio is 2.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Xiamen Amoytop Biotech Co's current PB Ratio is 6.82, which is 42% below median its own 10-year median of 11.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xiamen Amoytop Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Xiamen Amoytop Biotech Co (SHSE:688278) is currently considered Possible Value Trap. The stock's GF Value™ is ¥106.91, compared to a current price of ¥60.63 — trading 43.3% below its estimated fair value. The current PB Ratio is 6.82, which is 42% below median its 10-year median of 11.72 and 144.9% above the Biotechnology industry median of 2.79. Xiamen Amoytop Biotech Co's overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Xiamen Amoytop Biotech Co (SHSE:688278), the current PB Ratio is 6.82 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Xiamen Amoytop Biotech Co (SHSE:688278) Overvalued in 2026?
Based on GuruFocus' analysis, Xiamen Amoytop Biotech Co stock appears to be undervalued.
The current stock price of ¥60.63 is trading 43.3% below its estimated GF Value™ of ¥106.91.
GuruFocus considers Xiamen Amoytop Biotech Co to be Possible Value Trap.
Key valuation signals for SHSE:688278:
PB Ratio: 6.82 (42% below median its 10-year median of 11.72)
GF Value™: ¥106.91 vs. price of ¥60.63 (43.3% below fair value)
Industry Position: 144.9% above the Biotechnology median (#960 of 1230)
No single metric tells the full story. See the SHSE:688278 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Xiamen Amoytop Biotech Co Ltd operates as a drug development company. The Company develops and sells protein drugs, interferon drugs, and other products.
75GF Score
Get the complete analysis for SHSE:688278
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688278 has been successfully added to your 
